Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations

	Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations
Source Publication	SCIENCE ADVANCES
	2018
Volume	4 Issue:11 Pages:文献号 eaau0731：1-11
	Jaesung P.Choi; Rui Wang; Xi Yang; Xian Wang; Lu Wang; Ka Ka Ting; Matthew Foley; Victoria Cogger; Zhuo Yang; Liu F(刘峰); Han ZM(韩之明); Renjing Liu; Jonathan Baell; Xiangjian Zheng
Document Type	期刊论文
Identifier	http://ir.ioz.ac.cn/handle/000000/13477
Collection	干细胞与生殖生物学国家重点实验室
Recommended Citation GB/T 7714	Jaesung P.Choi,Rui Wang,Xi Yang,et al. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations[J]. SCIENCE ADVANCES,2018,4(11):文献号 eaau0731：1-11.
APA	Jaesung P.Choi.,Rui Wang.,Xi Yang.,Xian Wang.,Lu Wang.,...&Xiangjian Zheng.(2018).Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.SCIENCE ADVANCES,4(11),文献号 eaau0731：1-11.
MLA	Jaesung P.Choi,et al."Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations".SCIENCE ADVANCES 4.11(2018):文献号 eaau0731：1-11.

Related Services

Bookmark

Google Scholar

Similar articles in Bing Scholar

Terms of Use

No data!

Social Bookmark/Share

File name:	Ponatinib (AP24534) inhibits MEKK3-KLF.pdf
Format:	Adobe PDF

All comments (0)

No comment.

The comment function is only available to registered usersLog In

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Institution:
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh

中国科学院动物研究所机构知识库